|
Semantic Laboratories
|
info@semanticlaboratories.com La Jolla, CA |
|
The Critical Path to New Medical Products - FDA directive for addressing the bottlenecks in drug discovery development |
|
Guidance for Industry: Pharmacogenomics data - FDA guidance on the submission of pharmacogenomics data submission |
|
Personalized Medicine - FDA presentation on the impact of personalized medicine |
|
EDKB - Endocrine Disruptor Knowledgebase |
|
Regulatory Research Perspectives - March 2005 Issue |
|
CDER Data Standards Manual - a compilation of standardized nomenclature monographs |
|
Drug Development Science: Obstacles and Opportunities for Collaboration Among Academia, Industry and Government - A joint report produced by the AAMC and the U.S. Food and Drug Administration examines critical steps necessary to accelerate drug discovery and development. |
|
The Critical Path to New Medical Products - FDA directive for addressing the bottlenecks in drug discovery development |
|
Guidance for Industry: Pharmacogenomics data - FDA guidance on the submission of pharmacogenomics data submission |
|
Personalized Medicine - FDA presentation on the impact of personalized medicine |
|
EDKB - Endocrine Disruptor Knowledgebase |
|
Regulatory Research Perspectives - March 2005 Issue |
|
Drug Development Science: Obstacles and Opportunities for Collaboration Among Academia, Industry and Government - A joint report produced by the AAMC and the U.S. Food and Drug Administration examines critical steps necessary to accelerate drug discovery and development. |